Clinical Trials Logo

Clinical Trial Summary

This is a single-dose, randomized, double-blind, active-controlled, split-face, multiple centers, non-inferiority study. Approximately 50 nasolabial fold subjects will be enrolled. Each enrolled subject will be randomized equally into one of the following groups: 1. Group 1: right face will be injected with PBF PLLA microsphere, and left face with Sculptra® 2. Group 2: right face will be injected with Sculptra® and left face with PBF PLLA microsphere Subjects will be administrated on Visit 1 by applying PBF PLLA microsphere on one side of face and Sculptra® on the other.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06013332
Study type Interventional
Source Taipei Medical University Hospital
Contact Hsiou-Hsin Tsai, M.D. PhD.
Phone +886-2-2737-2181
Email tsaihh2000@yahoo.com.tw
Status Recruiting
Phase N/A
Start date April 15, 2024
Completion date December 2025

See also
  Status Clinical Trial Phase
Completed NCT00444210 - DL6049 vs CosmoPlast in the Treatment of Nasolabial Fold Wrinkles Phase 3
Not yet recruiting NCT05162326 - BC-101 in Treatment of Nasolabial Fold Wrinkles Phase 1
Completed NCT00444353 - DL6049 Versus Cosmoplast in the Treatment of Nasolabial Fold Wrinkles, Long Term Follow-up Phase 3